Nutritional Concepts

Here's a finding that challenges the "lower LDL is always better" narrative — and it's one every patient on a statin or aggressive lipid-lowering protocol should know about.

A study published in Cardiovascular Diabetology followed adults with no prior history of type 2 diabetes or cardiovascular disease and tracked who developed diabetes over time. The result: those with the lowest LDL cholesterol levels (under 84 mg/dL) had the highest risk of developing type 2 diabetes. Overall, 13% of participants developed diabetes — but that number jumped to 20% among statin users, compared to just 6% among non-users. The relationship between lower LDL and higher diabetes risk held across the analysis.

This matters because current ACC/American Heart Association guidelines are pushing LDL targets below 70 mg/dL for many patients. That's an aggressive target, and findings like this are a reminder that optimizing one number in isolation can come with trade-offs elsewhere. Comprehensive cardiometabolic assessment — not just LDL — is the standard we apply at Nutritional Concepts.

Most people have heard of uric acid in the context of gout or kidney stones — but there's a much bigger story here that doesn't get nearly enough attention.

A study published in Nutrition Journal tracked uric acid levels across the full cardiometabolic disease progression — from first diagnosis, to developing multiple conditions simultaneously, all the way to mortality. The finding was striking: every 1 mg/dL increase in serum uric acid above the normal range was independently associated with higher risk at every stage of that progression. That makes it one of the more actionable inflammation-linked biomarkers available on a standard blood panel.

This is exactly why uric acid is part of the blood work we review at Nutritional Concepts. It's an inexpensive, underutilized test that can surface cardiometabolic risk years before a diagnosis. If you haven't had yours checked recently — or don't know what your number means — it's worth a conversation.

Here's something worth sitting with: you can live with depression or anxiety and still experience genuine mental well-being. That's one of the most meaningful findings from a landmark international consensus just published in Nature Mental Health.

After surveying 122 specialists across psychiatry, medicine, economics, and philosophy, researchers identified 19 core dimensions of positive mental health. Six reached near-unanimous agreement: meaning and purpose, life satisfaction, self-acceptance, connection, autonomy, and happiness. The framework defines mental well-being not as a single feeling, but as the combination of how we feel emotionally, how we function psychologically, and how we connect with others — even when life is hard.

One more important distinction: things like income, physical health, and coping strategies were classified as drivers of mental health, not components of it. That's a significant shift in how we think about measuring and supporting well-being — and it's one we find deeply relevant in our work with patients every day.

If you've ever wondered whether magnesium is worth the hype — the research keeps saying yes. A wave of recent studies across multiple peer-reviewed journals points to magnesium's role in reducing inflammation (measured by C-reactive protein), supporting healthy pregnancies, protecting against gout, improving sleep quality, and even helping stabilize blood sugar in older adults with pre-diabetes.

What makes this mineral so versatile? Magnesium plays a role in over 300 enzymatic reactions — from energy metabolism to neuromuscular signaling to uric acid regulation. Low intake shows up in surprising places: higher perceived stress, worse headache impact, and greater weight gain risk in adolescent girls.

One important reminder: if you take synthetic thyroid medication, wait at least 2–4 hours before taking magnesium to avoid absorption interference. As always, we're here to help you find the right form and dose for your specific needs.